| 1 |
34913726 | The BET Protein Inhibitor Apabetalone Rescues Diabetes-Induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1. | 2022 Apr |
2 |
| 2 |
32821285 | Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease. | 2020 |
1 |
| 3 |
30476723 | Apabetalone downregulates factors and pathways associated with vascular calcification. | 2019 Jan |
3 |
| 4 |
31257080 | Design, synthesis and biological evaluation of hypolipidemic compounds based on BRD4 inhibitor RVX-208. | 2019 Aug 15 |
2 |
| 5 |
31300040 | Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism. | 2019 Jul 12 |
1 |